Nuo Therapeutics Inc. (AURX)
Market Closed
17 Jul, 20:00
OTC PINK OTC PINK Primary $
1. 00
+0.02
+2.0408%
$
47.44M Market Cap
- P/E Ratio
- Div Yield
3,500 Volume
- Eps
$ 0.98
Previous Close Want to track AURX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.1 |
| | | - | - |
| | | - | - |
| | | - | 0.01 |
| | | - | 0.02 |
| | | - | 0.02 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
AURX Earnings Reports FAQ
What is the earnings per share (EPS) for AURX?
EPS data for AURX is currently not available, as Nuo Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 335.86%, reflecting the AURX's performance and OTC PINK market conditions.
When is the next earnings release date?
Nuo Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nuo Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AURX at this time, as Nuo Therapeutics Inc has no recent EPS data to calculate it.
